Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
http://www1.actelion.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
0.4 seconds
16x16
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
106
SITE IP
63.83.5.110
LOAD TIME
0.416 sec
SCORE
6.2
Actelion Pharmaceuticals Ltd - Shaping our Future | www1.actelion.com Reviews
https://www1.actelion.com
Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
www1.actelion.com
Results Day Center
http://www1.actelion.com/sites/en/investors/results-day-center/index.page
Dissemination of clinical trial information. Adverse event reporting form. Drug discovery and development. Contact Global medical information. Actelion Center - Allschwil. You are here: Home. On 21 July 2016, Actelion announced its financial results for the first six months of 2016. Media Release English (0.2 MB). Media Release German (0.2 MB). Half Year 2016 Business Report. Half Year 2016 Financial Report. Reconciliations US-GAAP to core results - Quarterly. Biographies of webcast participants. The arc...
financial-half-year
http://www1.actelion.com/sites/en/journalists/newsroom/financial-half-year.page
Dissemination of clinical trial information. Adverse event reporting form. Drug discovery and development. Contact Global medical information. Actelion Center - Allschwil. You are here: Home. On 21 July, Actelion announced its financial results for the first six months of 2016. Find information on this page to help you with your article. Media Release English (0.2 MB). Media Release German (0.2 MB). Jean-Paul Clozel, M.D and Chief Executive Officer. High resolution image download. Publish or share it on:.
Half year report
http://www1.actelion.com/sites/en/investors/annual-report/half-year-report.page
Dissemination of clinical trial information. Adverse event reporting form. Drug discovery and development. Contact Global medical information. Actelion Center - Allschwil. You are here: Home. On 21 July 2016, Actelion published the financial results for the first six months of 2016 together with the Half-Year Report. We provide a versatile electronic format to download. This allows you to easily navigate through the report and focus on the information most important to your needs. Publish or share it on:.
TOTAL PAGES IN THIS WEBSITE
3
What is Niemann-Pick Type C (NPC) | Niemann-Pick Children's Fund, Inc
http://www.npcfund.org/niemann-pick-type-c.html
Niemann-Pick Children's Fund, Inc. A Rare Lysosomal Storage Disease. News & Events. Niemann Pick Type A and B. Patient Bill of Rights. Tips For Insurance Coverage. What is Niemann-Pick Type C Disease (NPC)? NPC is apart of the Lysosomal Storage Disorder family that encompasses about 50-60 diseases under the umbrella. You may have heard of more common Lysosomal Diseases such as Tay Sachs, Battens, Pompe Disease, Gaucher Disease, and many more. Life Expectancy with Niemann Pick Type C Disease. No clear and...
Sponsorship | 40th World Congress of the International College of Surgeons
http://www.icskyoto2016.jp/sponsorship.html
40th World Congress of. The International College of. 62nd Annual Congress of. The International College of. Takaragaike, Sakyo-ku, Kyoto. 40th ICS World Congress Secretariat. C/o ISS, INC. Mita MT Bldg. 8F, 3-13-12 Mita,. Minato-ku, Tokyo 108-0073, Japan. International College of Surgeons Japan Section. TEL: 81-3-3353-8111 Ext.25229. EMail: info@ics-japan.org. Package Sponsor and Sponsored Seminar Prospectus(JAPANESE).
phaware press releases — phaware.global
http://www.phaware.global/phaware-press-releases
PH BY THE NUMBERS. ON AIR WITH PHAWARE. Rose Colored Mask Blog. In Life With PH Blog. Stanford Race Against PH. Rare Disease Day 2016. PH BY THE NUMBERS. ON AIR WITH PHAWARE. Rose Colored Mask Blog. In Life With PH Blog. Stanford Race Against PH. Rare Disease Day 2016. ON AIR WITH PHAWARE. Rose Colored Mask Blog. In Life With PH Blog. Press REleases and news articles. H Awareness Night: Breathless On Broadway. Pulmonary Hypertension News 7/4/16. Phaware: How a Global Network for PH Awareness Got Started.
TOTAL LINKS TO THIS WEBSITE
106
Accueil
Actelion dans le monde. Hypertension Artérielle Pulmonaire (HTAP). Déclarer un événement indésirable. Vous êtes ici : Accueil. Actelion Pharmaceuticals Ltd est une entreprise biopharmaceutique spécialisée dans la découverte, le développement et la commercialisation de traitements innovants répondant aux problèmes médicaux non satisfaits. Pour en savoir plus. Pour en savoir plus. Actelion Pharmaceuticals Belgium NV. 32 15 284 777. 32 15 284 779. Notre spécialité. Le portefeuille de traitements d'Actelion ...
Actelion Pharma Schweiz AG
Pulmonale arterielle Hypertonie (PAH). Morbus Niemann-Pick Typ C (NP-C). Sie sind hier: Startseite. Actelion ist ein biopharmazeutisches Unternehmen mit eigenen Nieder-lassungen in mehr als 30 Ländern, das Medikamente für bisher unzureichend behandelbare Krankheiten erforscht, entwickelt und vermarktet. Actelion Pharma Schweiz AG stellt sich vor. Actelion Pharma Schweiz AG ist die. Schweizer Niederlassung von Actelion. Mit Sitz in Baden. Actelion Pharma Schweiz AG ist die. Mit Sitz in Baden. Die Gaucher-...
Actelion Pharmaceuticals Japan Ltd.
12507;ーム. 30740;究･開発. 30740;究･開発戦略. 12491;ュースリリース. 12450;カデミアプライズ. Super Car Race Series and Kids Traffic Safety School Projects. 12362;問い合わせ. 12507;ーム. 2015/03/26 肺動脈性肺高血圧症に対するオプスミット マシテンタン の製造販売承認を取得. 2013/11/08 肺動脈性肺高血圧症治療薬オプスミット 一般名 マシテンタン 米国FDAより適応を承認. 2013/06/24 肺動脈性肺高血圧症治療薬エポプロステノール静注用 ACT 販売を開始. 2015/03/26 肺動脈性肺高血圧症に対するオプスミット マシテンタン の製造販売承認を取得. 2013/11/08 肺動脈性肺高血圧症治療薬オプスミット 一般名 マシテンタン 米国FDAより適応を承認. 2013/06/24 肺動脈性肺高血圧症治療薬エポプロステノール静注用 ACT 販売を開始. 患者様やご家族の判断で服用 使用 を中止したり、用法 用量を変えたりすると危険な場合があります。
Actelion Pharmaceuticals Korea Ltd.
54924;사정보. 44592;업전략. 48372;도자료. 52292;용정보. 44544;로벌 악텔리온. 50724;시는길. 51228;품정보. 53944;라클리어. 51088;베스카. 49888;약개발. 50672;구개발. 52824;료분야. 44060;발현황. 악텔리온 파마수티컬즈 코리아 (Actelion Pharmaceuticals Korea) 는 혁신적인 신약의 연구개발 및 제품화에 주력하고 있는 Actelion Ltd. (본사: 스위스) 의 한국 법인입니다. 폐동맥 고혈압(Pulmonary Arterial Hypertension)은 폐와 심장을 연결해주는 동맥(폐동맥)에서 나타나는 심각한 질병입니다. 폐동맥 고혈압(Pulmonary Arterial Hypertension)은 폐와 심장을 연결해주는 동맥(폐동맥)에서 나타나는 심각한 질병입니다. Actelion 은 주요 30개국에 지사를 두고 있습니다. Actelion Pharmaceuticals Korea Ltd.
Actelion Pharmaceuticals UK Ltd
Actelion UK and Ireland. A day in the life. Report an adverse event. You are here: Home. Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Switzerland. Actelion focuses on the discovery, development and commercialisation of innovative treatments to serve high unmet medical needs. The Actelion UK and Ireland office was established in 2001 with four employees in a small office in London. We have now expanded to over 40 employees. Are you a patient or caregiver looking for informa...
Actelion Pharmaceuticals Ltd - Shaping our Future
Adverse event reporting form. Drug discovery and development. Contact Global medical information. Actelion Center - Allschwil. You are here: Home. On the discovery,. Jean-Paul Clozel, CEO "We have had. An excellent first half of the year with. For our products.". Investors: Results Day Center. Jean-Paul Clozel, CEO "We have had. An excellent first half of the year with. For our products.". Investors: Results Day Center. Actelion delivers excellent first half 2015 results. ATLN SIX Swiss Exchange.
Actelion Pharmaceuticals do Brasil Ltd
Informações Gerais. Informações Gerais. Hipertensão arterial pulmonar (HAP). Doença de Gaucher tipo 1 (DG1). Profissional de saúde. Informações Gerais. Hipertensão arterial pulmonar (HAP). Doença de Gaucher tipo 1 (DG1). Informações Gerais. Você está aqui: Página Inicial. Em 2002, a Actelion inaugurou o seu primeiro. Escritório na América Latina. Por seu potencial de crescimento farmacêutico. E por ser considerado um dos maiores centros. De pesquisa de referência no continente,.
Actelion Pharmaceuticals CZ
218;vodní stránka. Actelion CZ and SK. Výroční zpráva. Odborná veřejnost. Léčivé přípravky. Centra pro léčbu. Nacházíte se zde: Úvodní stránka. Actelion Pharmaceuticals Ltd je biofarmaceutická společnost s ústředím ve švýcarském Allschwilu u Basileje, která se zaměřuje na objevování, vývoj a komercionalizaci inovativních léků, řešících dosud nesplněné potřeby v medicíně. ACTELION PHARMACEUTICALS CZ and SK. Actelion Pharmaceuticals CZ and SK. Actelion Pharmaceuticals CZ and SK. 120 00 Praha 2.
Actelion Pharmaceuticals Deutschland GmbH
Pulmonal arterielle Hypertonie (PAH). Morbus Niemann-Pick Typ C (NP-C). Sie sind hier: Startseite. Actelion ist ein biopharmazeutisches Unternehmen, das Medikamente für bisher unzureichend behandelbare Krankheiten erforscht, entwickelt und vermarktet. Actelion ist in mehr als 30 Ländern mit eigenen Niederlassungen vertreten. ACTELION STELLT SICH VOR. Actelion hat sich vom Pionier in der Erforschung. Und Anwendung von Endothelin-Rezeptor-. Antagonisten zu einem wissenschaftlich und. 49 (0)761 4564 0.
Actelion Pharmaceuticals France SAS
Actelion en général. Sclérodermie Systémique. Professionnels de santé. Sclérodermie Systémique. Emplois et carrières. Vous êtes ici: Accueil. Actelion est une société biopharmaceutique, qui se trouve près de Bâle, spécialisée dans la découverte, le développement et la commercialisation de traitements innovants répondant aux problèmes médicaux non satisfaits. Notre culture d’entreprise se fonde sur la passion pour l’innovation scientifique. Actelion crée une valeur exceptionnelle aussi bien. Actelion s'en...
Actelion Pharmaceuticals Italia
La responsabilità sociale dell'azienda. Segnalazione di sospetta reazione avversa. Ipertensione Arteriosa Polmonare (PAH). La malattia di Gaucher. La malattia di Niemann-Pick tipo C. Segnalazione di un effetto indesiderato. Tu sei qui: Home. Actelion è un’azienda biofarmaceutica con sede in Svizzera a Basilea, impegnata nella ricerca,. Sviluppo e commercializzazione di terapie innovative per malattie prive di opzioni terapeutiche. Actelion Pharmaceuticals Italia s.r.l. Via Lasie, 10/L.
SOCIAL ENGAGEMENT